Literature DB >> 20667055

Use of a disease-specific instrument in economic evaluations: mapping WOMAC onto the EQ-5D utility index.

Feng Xie1, Eleanor M Pullenayegum, Shu-Chuen Li, Robert Hopkins, Julian Thumboo, Ngai-Nung Lo.   

Abstract

OBJECTIVE: To map the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) onto the EuroQol 5 Dimension (EQ-5D) utility index in patients with knee osteoarthritis (OA).
METHODS: A consecutive sample of patients (n=258) diagnosed with knee OA completed both the WOMAC and the EQ-5D. Regression models with the ordinary least squares (OLS) or the censored least absolute deviations as the estimator were used to establish the mapping function. The WOMAC was represented as explanatory variables in four ways: 1) total score; 2) domain scores (i.e., pain, stiffness, and physical function); 3) domain scores plus pair-wise interaction terms to account for possible nonlinearities; and 4) individual item scores. Goodness-of-fit criteria included the mean absolute error (the primary criterion) and the root mean squared error, and were obtained using an iterative random sampling procedure. Prediction precision was evaluated at individual patient level and at the group level.
RESULTS: The model using the OLS estimator and the WOMAC domain scores as explanatory variables had the best fit and was chosen as the preferred mapping model. The prediction error at the individual level exceeded the maximal tolerance value (i.e., the minimally important difference of the EQ-5D) in about 16% of the patients. At the group level, the width of the 95% confidence interval of prediction errors varied from 0.0176 at a sample size of 400 to 0.0359 at a sample size of 100.
CONCLUSIONS: EQ-5D scores can be predicted using WOMAC domain scores with an acceptable precision at both individual and group levels in patients with mild to moderate knee OA.
© 2010, International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

Entities:  

Mesh:

Year:  2010        PMID: 20667055     DOI: 10.1111/j.1524-4733.2010.00770.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  18 in total

Review 1.  Evaluation of content on EQ-5D as compared to disease-specific utility measures.

Authors:  Fang-Ju Lin; Louise Longworth; A Simon Pickard
Journal:  Qual Life Res       Date:  2012-06-23       Impact factor: 4.147

2.  Measuring health-related quality of life among adults in Singapore: population norms for the EQ-5D.

Authors:  Edimansyah Abdin; Mythily Subramaniam; Janhavi Ajit Vaingankar; Nan Luo; Siow Ann Chong
Journal:  Qual Life Res       Date:  2013-04-03       Impact factor: 4.147

3.  Considering productivity loss in cost-effectiveness analysis: a new approach.

Authors:  Afschin Gandjour
Journal:  Eur J Health Econ       Date:  2014-11

4.  Association between knee symptoms, change in knee symptoms over 6-9 years, and SF-6D health state utility among middle-aged Australians.

Authors:  Ambrish Singh; Julie A Campbell; Alison Venn; Graeme Jones; Leigh Blizzard; Andrew J Palmer; Terence Dwyer; Flavia Cicuttini; Changhai Ding; Benny Antony
Journal:  Qual Life Res       Date:  2021-05-03       Impact factor: 4.147

5.  Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.

Authors:  Ning Yan Gu; Chris Bell; Marc F Botteman; Xiang Ji; John A Carter; Ben van Hout
Journal:  Patient       Date:  2012       Impact factor: 3.883

6.  Mapping of the PDQ-39 to EQ-5D scores in patients with Parkinson's disease.

Authors:  Megan K Young; Shu-Kay Ng; George Mellick; Paul A Scuffham
Journal:  Qual Life Res       Date:  2012-07-11       Impact factor: 4.147

7.  Using WOMAC Index scores and personal characteristics to estimate Assessment of Quality of Life utility scores in people with hip and knee joint disease.

Authors:  Ilana N Ackerman; Mark A Tacey; Zanfina Ademi; Megan A Bohensky; Danny Liew; Caroline A Brand
Journal:  Qual Life Res       Date:  2014-03-14       Impact factor: 4.147

8.  Hospital Inpatient versus HOme-based rehabilitation after knee arthroplasty (The HIHO study): study protocol for a randomized controlled trial.

Authors:  Mark A Buhagiar; Justine M Naylor; Ian A Harris; Wei Xuan; Friedbert Kohler; Rachael J Wright; Renee Fortunato
Journal:  Trials       Date:  2013-12-17       Impact factor: 2.279

9.  Use of Bayesian multivariate meta-analysis to estimate the HAQ for mapping onto the EQ-5D questionnaire in rheumatoid arthritis.

Authors:  Sylwia Bujkiewicz; John R Thompson; Alex J Sutton; Nicola J Cooper; Mark J Harrison; Deborah P M Symmons; Keith R Abrams
Journal:  Value Health       Date:  2014 Jan-Feb       Impact factor: 5.725

10.  Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D.

Authors:  Allan Wailoo; Monica Hernandez Alava; Antonio Escobar Martinez
Journal:  Health Qual Life Outcomes       Date:  2014-03-12       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.